{"name":"Encoded Therapeutics","slug":"encoded-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikgJBVV95cUxOV2dQdWhJUEVCYjc5TXl6ZlB5WnhkV3VmZE1iT1R3VXJidWlCQnppU2R3XzBqWlk2WDVqZGJTWWJmOHc4aEtuR3dHRFdvNUlVajBSalY3ZTk2b0g2UXdhbm1Vb0dyODhQcW9ENl8tXzNDbDlvbW9HM1FPT2t3WEQ1bGJ6NDJQS3BBX1ZyR2cxMU5COTlRRHZtSkVjdW5veUxMeExFY1k5MmRuUkZ2NDI4dVJiX1N4c1ozVnZqSldiRWUzSFBfUEhIV2p3eWc2WXljUENOYWR0clRya1hBWWxUSzAyMW9vaWRWUmx5UlVqWDlVdjBaeDR0N20zem5RZzU3dDR0blAwSkd5SWZBbzB6Z3lB?oc=5","date":"2026-01-12","type":"regulatory","source":"Business Wire","summary":"Encoded Therapeutics Announces U.S. FDA Breakthrough Therapy Designation Granted to ETX101 for the Treatment of Dravet Syndrome - Business Wire","headline":"Encoded Therapeutics Announces U.S. FDA Breakthrough Therapy Designation Granted to ETX101 for the Treatment of Dravet S","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPUXVENkVoVWpFRTRLQjR1NW5fN2tsemdDT0ctcjZnQ3k4Vno3Ul9pYXJZTGJvUTcyYW1rc2VublRPWFJmZ2NKeWVBVjl3NUpaS1ZpSlRjRDk1UEd4RUxVS2taSGF3bWVpOGZMSlM0Wi00SjVlN3NMQkFPZFg2a0ozbm42WmduYndhaEphOElpNGMzYWdDSWxOTnpfLWc?oc=5","date":"2026-01-12","type":"trial","source":"BioWorld News","summary":"Phase III update Stokes hope; Dravet game-change Encoded? - BioWorld News","headline":"Phase III update Stokes hope; Dravet game-change Encoded?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxNQjBCVzFIR0RXZ2thMmhXbXZ4cEltbDhpZ19WN3FGT3RzdEJHTkk5M29qWTk1S2JLZWpJMk9Td3BlZEF6d1RCN1hkRFRSVUM3cFhub0w1cHFDZVZDN0pBdy1pemFaeXN5RWw2Wmp0YmZTTXVwUkZEdXFENEg5bEp3LWFLaDh6b3lNaEgyMy1FUlVFZUNKNHV4cFN3QmpSV0RuaFliRUlPMkgtc3QzN0FHSTNFVTV6TWdTVkVHOFN4N21NRi1vY1F0TGVTeV9nbERsMnhBbGNiRnFlRjdYbWRtbXRzdnVERVVKbG13YV9SOHNfZw?oc=5","date":"2026-01-05","type":"pipeline","source":"Business Wire","summary":"Encoded Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026 - Business Wire","headline":"Encoded Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxOQmhkQlJQRzJzbGVrREo5Vnh4MW9FbTBRSGF0VWp3N2ptTktmaFBxQXZVemdGSHVSc3Y3R2ZnY0U1clpmY1pTN0I5R0d6bXpjb0pnOHZWMF9KS0NoemZud0otYVZQOFRnNHF6dW15c3R5ZDNkcWo3RlZJTFVCNDg5MGl6ZDIzcGhxM1ZkNVln?oc=5","date":"2025-12-19","type":"pipeline","source":"Fierce Biotech","summary":"Pfizer RNA leader runs to Replicate—Chutes & Ladders - Fierce Biotech","headline":"Pfizer RNA leader runs to Replicate—Chutes & Ladders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQVHBiMldueDlxVHZzVm9waElSbGhSX3ZHRlZBaEtwZy1feFRaUzE5SzBzOUN4TEJpYWJYYTR1VjYwa2F4YVZJY3dPWGVkNXFrUXNpN0dJdFFYcjZkV1ktMGZsaXNHVXRPcGo2TTgwNVk4b1Z2RzNfS1dCSjlCUUEyUGFPOVJrQTVqUm5uUHRBYXJueXdkblk1Y25pd3dlNERlVFM5cDJWM05KSnFB?oc=5","date":"2025-12-05","type":"trial","source":"Fierce Biotech","summary":"Encoded deciphers path to pivotal trial with phase 1/2 Dravet gene therapy data - Fierce Biotech","headline":"Encoded deciphers path to pivotal trial with phase 1/2 Dravet gene therapy data","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgJBVV95cUxNd295YjBpRnRVcFQwa1JMUmdyeXdaV3NzTmxzal9GUVhRNk9HQTcyWFpYRHM1U0M2T195NUt4TUVwOU5nZXRoZHdXZ0ZpbjNMaDlrTE5QVDl0ZVpMcmJaMEtXTEZ2V2ZUdWdmMmt1QnhIMERfUUhtdEtiX3ZpaHltTzdOMDU5Zll3MW5GdHRzdmdzM0FBOUdtQkFlVFJsTTAyNGVMdFlwTjBkdnRzcWNCejlrcHhpWkVubEVFNTd2MmVMRkpqVGJkUEphNGFzaVRsaTRKTmh6aXdYVjRxLW5yTjQ3TE5Xd1ltS053akpVMjZSdDVtclJBTzB0cEMtQkVDZ2dqX3dsZk9HZGZFOV9FZnFONEl1QQ?oc=5","date":"2025-10-10","type":"trial","source":"BioSpace","summary":"New Preclinical Data from Encoded Therapeutics Demonstrate Therapeutic Potential of its One-time, Non-opioid Gene Therapy Candidate for Chronic Pain - BioSpace","headline":"New Preclinical Data from Encoded Therapeutics Demonstrate Therapeutic Potential of its One-time, Non-opioid Gene Therap","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgJBVV95cUxNY2RmcTlVdXJMNUdzdHZEdktPZkNwYUxSWEMtN0otZUxVTU1GTWxiTHJCYW93YWY5VDB6T1F5N1BZVUtCcUdXZDZ0eU1ZSUhnUWtpRFBJUGlJdWViRDlUYnBRMFJ2QXR1eGF0U1pPb2RqTmFkSTA2VUVVdUdGdGhlRlhtSk1iMW4tczRSTlNYRWNtSWN4anRKQXdaaFVWQkpUaFdRMVdleFp6TU1KUnR4WDhTSW0xRmt2MmhjbTRsa2FocjBvRmt1Z1dpNU9DQWNMSHdIQzdIWHhwYmtqUE0tQjhpVmxtMjJKeWptWGhTVkpqQWktMWlMOURVelBEQVh3cjVzbWFkdHZSNHNIVUZnR3loV2FoWkRHSy1ydjBSTDdGY0hoU0E?oc=5","date":"2025-09-02","type":"regulatory","source":"Business Wire","summary":"Encoded Therapeutics Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by U.S. FDA for ETX101 in SCN1A+ Dravet Syndrome - Business Wire","headline":"Encoded Therapeutics Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by U.S. FDA for ETX101 ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQd0o3TnhUMGZkeEI3YlJyaHlpN0xzOExtLXVlYUs4NUFNT2JsTmMwVkJfc2t4NE1aWkVEQkFiS3FieFFVUlVJTUhCcXZGR3pVNzg3d2UwSFZlS09yZ3VXRjB2b05kQ1E2azV6cjh2a1d6c0VGY1pVdGVubjhrUkhqamQxN18ybnY2cXlHNXBMMFU?oc=5","date":"2025-08-27","type":"earnings","source":"seekingalpha.com","summary":"Stoke Therapeutics: Vulnerable To Profit Taking (NASDAQ:STOK) - seekingalpha.com","headline":"Stoke Therapeutics: Vulnerable To Profit Taking (NASDAQ:STOK)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxOTXB0bWNSbDdRVlZjMERDNU5vQWxmTkJtUWxSVHRCeHYwNmtkeGpLZTNBOVJTdWh2X2dKcW00TEZJeGo4QVZxNzE3YmJMSzFOZnJMLXVwTTk2cERhVVk2S0tZZ0JDaHdUbnVVVWc1TlhmNm96NUx4Yjk4cGp6VThWbW5WNWE3QUNKMTFSNWx2Q3FCOHFoVC1CNDN5cWdYVVcwNDNIQzV3?oc=5","date":"2025-02-13","type":"pipeline","source":"BioSpace","summary":"Encoded Cuts 29% of Workforce to Extend Cash Runway, Advance Pipeline - BioSpace","headline":"Encoded Cuts 29% of Workforce to Extend Cash Runway, Advance Pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQdWlObkppY1p0U2RPaGdqRUw5bUxHbnd4cHJIX3V3akJibWF2OTZQUW0tRzVLcjhmY1NqbGI4Y2x1SlFLRldhQm5jZEZ3aDRXSmJyeW9xbmZSXzNDQXJvU1FPcWVyRHRGQmpsN2FJZmFTS2IwY2tHbGpmUXE4ZWh5UlhUZFZucHcyelN1Y283QWtQazA5TlNrdjFhTTRRNzNr?oc=5","date":"2025-02-13","type":"trial","source":"Fierce Biotech","summary":"Encoded lays off 29% of staff to fund Dravet syndrome gene therapy trial - Fierce Biotech","headline":"Encoded lays off 29% of staff to fund Dravet syndrome gene therapy trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAJBVV95cUxNQmJPN3QyUVhtLUJ2Z0lrREo1amRfRWFKMW9Fazlhai13YWV0YUJ5eG11a1BZdTg4Tll4WWNacGR2eU1vX1dhQXhPMjRBX3U1cDRUSVVFQ2FVVS1JTkpIeFU3WnhLNU5QclZfZF9XajdWSG5qWWdlTmppRHNxQUp3Wmp3NXMtWXJZLXdPR2wwOVU2YnpTbXpoTUxFQU5YX29xWERZWjMwTlNYT25hUnRmVHcybWpDNEhfYUVDOVlVN05xdVRTS3dBSGwydERRWTNrU0xIenVYQWhWYi1DZkFtWVVMLWNxcEJNNUllb0NYQUhwY1Z3M01STy1oRTB5UXFDVzVTVkRZTTdOcEpDWEZ0NE9MU3VETHA4NU1ZY3VweF9jenVvRzRfUU9zMEladGxG?oc=5","date":"2025-02-13","type":"pipeline","source":"Business Wire","summary":"Encoded Therapeutics Reports Clinical Progress of ETX101 Gene Therapy for Dravet Syndrome, Recaps 2024 Corporate Achievements and Provides 2025 Outlook - Business Wire","headline":"Encoded Therapeutics Reports Clinical Progress of ETX101 Gene Therapy for Dravet Syndrome, Recaps 2024 Corporate Achieve","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxOTG9TVWxKTGxCZkFuTk9XX3hHcHUtOGlQbkFicTctUFBRN1lGV0tzVkxHdktsSkpFQ3JLSmp6LVJMWEk4QzVUem01bWlPdGtPanJKbVpYOGJiemNVSE1qbEdQUXdDZ2NOVnY5QXJSYVhqSk0zZDRGNVk3aHUtSWNJWnZjTUk2aHhiVU1UVm5FZ05nQ3lLOV9nVHdHbzVGY1RWd1ZCdDlKenkwVFY3OF9nLQ?oc=5","date":"2020-07-22","type":"pipeline","source":"Fierce Biotech","summary":"Encoded Therapeutics bags $135M to push 'precision gene therapy' into the clinic - Fierce Biotech","headline":"Encoded Therapeutics bags $135M to push 'precision gene therapy' into the clinic","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}